Table 1 Baseline characteristics of the study participants
Parameter | Total (n = 435) | Recurrent (n = 132) | Nonrecurrent (n = 303) | P-value |
|---|---|---|---|---|
Age (years) | 56.6 ± 10.7 | 58.6 ± 9.7 | 55.7 ± 10.9 | 0.008 |
Male (n, %) | 245(56.3%) | 92(69.7%) | 153(50.5%) | <  0.001 |
Follow-up (month) | 10.8 ± 4.5 | 11.7 ± 5.0 | 10.4 ± 4.2 | 0.003 |
BMI (kg/m2) | 23.2 ± 3.3 | 22.9 ± 3.2 | 24.0 ± 3.5 | 0.003 |
Drink (n, %) | 12(2.8%) | 8(6.1%) | 4(1.32%) | 0.009 |
Smoke (n, %) | 48(11.0%) | 18(13.6%) | 30(9.9%) | 0.249 |
Hypertension (n, %) | 83(19.1%) | 29(22.0%) | 54(17.2%) | 0.353 |
Diabetes Mellitus (n, %) | 30(6.9%) | 9(6.8%) | 21(6.9%) | 1.00 |
Dyslipidemia (n, %) | 117(26.9%) | 42(31.8%) | 75(24.8%) | 0.127 |
TC (mmol/L) | 5.49 ± 1.22 | 5.44 ± 1.23 | 5.40 ± 1.14 | 0.727 |
TG (mmol/L) | 1.72 ± 1.15 | 1.74 ± 1.24 | 1.44 ± 0.92 | 0.006 |
HDL-C (mmol/L) | 1.35 ± 0.33 | 1.32 ± 0.33 | 1.42 ± 0.38 | 0.008 |
LDL-C (mmol/L) | 3.21 ± 0.85 | 3.12 ± 0.85 | 3.08 ± 0.83 | 0.646 |
ApoA1(g/L) | 1.29 ± 0.33 | 1.28 ± 0.33 | 1.37 ± 0.40 | 0.033 |
ApoB(g/L) | 1.02 ± 0.28 | 0.97 ± 0.28 | 0.96 ± 0.28 | 0.653 |
TG/HDL | 1.47 ± 1.24 | 1.48 ± 1.37 | 1.16 ± 1.00 | 0.006 |